Skip to main content

Table 2 Sample population demographics for patients with macro- and microhematuria with complete data

From: A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma

Parameter

Patients with macrohematuria (N = 587), n (%)

Patients with microhematuria (N = 40), n (%)

Age, years

<40

8 (1.4)

21 (52.5)

40–49

47 (8.0)

50–59

107 (18.2)

60–69

143 (24.4)

19 (47.5)

70–79

181 (30.8)

80–100

101 (17.2)

Gender

Female

113 (19.3)

25 (62.5)

Male

474 (80.7)

15 (37.5)

Smoking history

Never smoked

246 (41.9)

25 (62.5)

Current or past smoker

341 (58.1)

15 (37.5)

Hfreq (events/day)

≤1

332 (56.6)

40 (100)

>1

255 (43.4)

Tumor stage

Normal

515 (87.7)

40 (100)

T1

16 (2.7)

T2

11 (1.9)

T3

2 (0.3)

Ta

40 (6.8)

Tis

3 (0.5)